600713 南京医药
交易中 03-31 14:55:18
资讯
新帖
简况
每周股票复盘：南京医药（600713）注销3.9852万股回购股份
证券之星 · 03-29 04:03
每周股票复盘：南京医药（600713）注销3.9852万股回购股份
股市必读：南京医药（600713）3月23日收盘跌6.38%，主力净流入515.21万元
证券之星 · 03-24
股市必读：南京医药（600713）3月23日收盘跌6.38%，主力净流入515.21万元
南京医药（600713）披露董事会成员调整及公司类型变更议案，3月20日股价下跌0.77%
证券之星 · 03-20
南京医药（600713）披露董事会成员调整及公司类型变更议案，3月20日股价下跌0.77%
每周股票复盘：南京医药（600713）两期超短融共募资10亿
证券之星 · 03-15
每周股票复盘：南京医药（600713）两期超短融共募资10亿
南京医药新注册《南京医药三方物流委托系统V1.0》等2个项目的软件著作权
证券之星 · 03-15
南京医药新注册《南京医药三方物流委托系统V1.0》等2个项目的软件著作权
南京医药（600713）披露2026年度第三期超短期融资券发行结果公告，3月9日股价下跌0.37%
证券之星 · 03-09
南京医药（600713）披露2026年度第三期超短期融资券发行结果公告，3月9日股价下跌0.37%
每周股票复盘：南京医药（600713）子公司使用4000万元闲置募资买理财
证券之星 · 03-08
每周股票复盘：南京医药（600713）子公司使用4000万元闲置募资买理财
南京医药（600713）披露子公司使用闲置募集资金购买结构性存款公告，3月5日股价上涨0.57%
证券之星 · 03-05
南京医药（600713）披露子公司使用闲置募集资金购买结构性存款公告，3月5日股价上涨0.57%
每周股票复盘：白云山（600332）广药二期基金完成收购南京医药11.04%股份
证券之星 · 03-01
每周股票复盘：白云山（600332）广药二期基金完成收购南京医药11.04%股份
南京医药（600713）披露持股5%以上股东协议转让股份过户完成公告，2月27日股价上涨0.36%
证券之星 · 02-27
南京医药（600713）披露持股5%以上股东协议转让股份过户完成公告，2月27日股价上涨0.36%
每周股票复盘：南京医药（600713）拟注销3.9852万股回购股份
证券之星 · 02-08
每周股票复盘：南京医药（600713）拟注销3.9852万股回购股份
南京医药（600713）披露2026年第一次临时股东会决议公告，2月5日股价下跌0.18%
证券之星 · 02-05
南京医药（600713）披露2026年第一次临时股东会决议公告，2月5日股价下跌0.18%
每周股票复盘：南京医药（600713）324名激励对象获解禁
证券之星 · 02-01
每周股票复盘：南京医药（600713）324名激励对象获解禁
南京医药（600713）447.67万股限售股将于1月30日解禁，占总股本0.34%
证券之星 · 01-30
南京医药（600713）447.67万股限售股将于1月30日解禁，占总股本0.34%
南京医药（600713）披露关于变更回购股份用途并注销的议案，1月28日股价下跌0.72%
证券之星 · 01-28
南京医药（600713）披露关于变更回购股份用途并注销的议案，1月28日股价下跌0.72%
南京医药（600713）披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁事项，1月26日股价上涨0.35%
证券之星 · 01-26
南京医药（600713）披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁事项，1月26日股价上涨0.35%
南京医药（600713）披露2026年度第一期超短期融资券发行结果，1月19日股价上涨0.73%
证券之星 · 01-19
南京医药（600713）披露2026年度第一期超短期融资券发行结果，1月19日股价上涨0.73%
每周股票复盘：南京医药（600713）子公司使用5000万元闲置募资买理财
证券之星 · 01-18
每周股票复盘：南京医药（600713）子公司使用5000万元闲置募资买理财
每周股票复盘：南京医药（600713）南药转债累计转股15,216股
证券之星 · 01-11
每周股票复盘：南京医药（600713）南药转债累计转股15,216股
南京医药（600713）披露公司及子公司使用部分暂时闲置募集资金进行现金管理到期赎回公告，1月9日股价上涨0.55%
证券之星 · 01-09
南京医药（600713）披露公司及子公司使用部分暂时闲置募集资金进行现金管理到期赎回公告，1月9日股价上涨0.55%
加载更多
公司概况
公司名称：
南京医药集团股份有限公司
所属行业：
零售业
上市日期：
1996-07-01
主营业务：
南京医药集团股份有限公司的主营业务是医药批发、医药零售、医药“互联网+”业务以及医药第三方物流服务业务。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务业务。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。
发行价格：
5.98
{"stockData":{"symbol":"600713","market":"SH","secType":"STK","nameCN":"南京医药","latestPrice":5.28,"timestamp":1774940118000,"preClose":5.24,"halted":0,"volume":15620765,"delay":0,"changeRate":0.0076,"floatShares":1290000000,"shares":1309000000,"eps":0.4055,"marketStatus":"交易中","change":0.04,"latestTime":"03-31 14:55:18","open":5.24,"high":5.35,"low":5.23,"amount":82957500,"amplitude":0.0229,"askPrice":5.29,"askSize":1584,"bidPrice":5.28,"bidSize":1422,"shortable":0,"etf":0,"ttmEps":0.4055,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774940400000},"marketStatusCode":2,"adr":0,"adjPreClose":5.24,"symbolType":"stock","openAndCloseTimeList":[[1774920600000,1774927800000],[1774933200000,1774940400000]],"highLimit":5.76,"lowLimit":4.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1308892753,"isCdr":false,"pbRate":0.98,"roa":"--","peRate":13.020962,"roe":"5.79%","epsLYR":0.438,"committee":0.012628,"marketValue":6911000000,"turnoverRate":0.0121,"status":0,"floatMarketCap":6810000000},"requestUrl":"/m/hq/s/600713","defaultTab":"news","newsList":[{"id":"2623338783","title":"每周股票复盘：南京医药（600713）注销3.9852万股回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2623338783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623338783?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:03","pubTimestamp":1774728194,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，南京医药报收于5.09元，较上周的5.17元下跌1.55%。本周关注点公司公告汇总：南京医药注销3.9852万股回购股份，注册资本相应减少。南京医药公告，因回购股份注销，根据《募集说明书》规定测算，本次注销3.9852万股，占总股本比例较小，转股价格经计算后仍为5.12元/股，保持不变。南京医药宣布将注销回购专用证券账户中剩余的3.9852万股股份，占注销前总股本的0.003%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621894550","title":"股市必读：南京医药（600713）3月23日收盘跌6.38%，主力净流入515.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621894550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621894550?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:26","pubTimestamp":1774293974,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，南京医药报收于4.84元，下跌6.38%，换手率1.45%，成交量18.76万手，成交额9285.29万元。当日关注点来自交易信息汇总：南京医药股价连续4日下跌，累计跌幅达8.96%，主力资金前10日净流出超1681万元。交易信息汇总3月23日南京医药收盘报4.84元，跌6.38%，当日成交1876.39万元。本次注销后，公司总股本将由1,308,932,605股变更为1,308,892,753股，回购专用证券账户不再持有公司股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620373817","title":"南京医药（600713）披露董事会成员调整及公司类型变更议案，3月20日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620373817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620373817?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:48","pubTimestamp":1774018099,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，南京医药报收于5.17元，较前一交易日下跌0.77%，最新总市值为67.67亿元。该股当日开盘5.2元，最高5.27元，最低5.16元，成交额达4197.46万元，换手率为0.63%。近日，南京医药发布2026年第二次临时股东会材料。上述事项已提交董事会审议通过，尚需提交股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000044027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619782731","title":"每周股票复盘：南京医药（600713）两期超短融共募资10亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2619782731","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619782731?lang=zh_cn&edition=full","pubTime":"2026-03-15 03:16","pubTimestamp":1773515773,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，南京医药报收于5.43元，较上周的5.37元上涨1.12%。本周，南京医药3月13日盘中最高价报5.47元。本期融资券代码012680557，简称26南京医药SCP003，期限270日，起息日2026年3月6日，兑付日2026年12月1日，发行利率1.52%，发行价格100元。南京医药于2026年3月6日发行第四期超短期融资券，发行总额5亿元，募集资金于3月9日到账，用途同上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600713","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619120350","title":"南京医药新注册《南京医药三方物流委托系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619120350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619120350?lang=zh_cn&edition=full","pubTime":"2026-03-15 01:49","pubTimestamp":1773510551,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南京医药新注册了2个项目的软件著作权，包括《南京医药三方物流委托系统V1.0》、《南京医药物流预约系统V1.0》等。今年以来南京医药新注册软件著作权2个。通过天眼查大数据分析，南京医药集团股份有限公司共对外投资了56家企业，参与招投标项目719次；财产线索方面有商标信息113条，专利信息6条，著作权信息20条；此外企业还拥有行政许可51个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618622944","title":"南京医药（600713）披露2026年度第三期超短期融资券发行结果公告，3月9日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618622944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618622944?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:24","pubTimestamp":1773066264,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘，南京医药报收于5.35元，较前一交易日下跌0.37%，最新总市值为70.03亿元。近日，南京医药集团股份有限公司披露《2026年度第三期超短期融资券发行结果公告》。公告显示，公司于2026年3月5日发行了2026年度第三期超短期融资券，发行总额为5亿元，实际发行总额5亿元，募集资金已于2026年3月6日到账，用于补充流动资金和偿还银行贷款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663333","title":"每周股票复盘：南京医药（600713）子公司使用4000万元闲置募资买理财","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663333","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663333?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:57","pubTimestamp":1772909828,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，南京医药报收于5.37元，较上周的5.52元下跌2.72%。本周，南京医药3月2日盘中最高价报5.51元。3月4日盘中最低价报5.22元。南京医药当前最新总市值70.29亿元，在医药商业板块市值排名16/32，在两市A股市值排名2746/5190。本周关注点公司公告汇总：子公司康捷物流使用4,000万元闲置募集资金购买平安银行结构性存款产品。该事项已经公司第十届董事会临时会议审议通过，额度在12个月内可滚动使用，不影响募投项目正常进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617172175","title":"南京医药（600713）披露子公司使用闲置募集资金购买结构性存款公告，3月5日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617172175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617172175?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:21","pubTimestamp":1772702465,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘，南京医药报收于5.28元，较前一交易日上涨0.57%，最新总市值为69.11亿元。该股当日开盘5.29元，最高5.32元，最低5.25元，成交额达4040.17万元，换手率为0.59%。南京医药于近日披露《关于公司子公司使用部分暂时闲置募集资金进行现金管理的进展公告》。公告显示，公司子公司康捷物流使用暂时闲置募集资金4,000万元购买平安银行对公结构性存款产品TGG26200057期，产品期限92天，起息日为2026年3月3日，年化收益率为1.00%或1.60%或1.70%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500027953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616843461","title":"每周股票复盘：白云山（600332）广药二期基金完成收购南京医药11.04%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843461","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843461?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:10","pubTimestamp":1772302223,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，白云山报收于25.29元，较上周的25.11元上涨0.72%。本周，白云山2月25日盘中最高价报25.41元。广药二期基金拟以自有资金通过协议转让方式收购Alliance Healthcare Asia Pacific Limited持有的南京医药144,557,431股非限售股份。2025年11月17日，广药二期基金获得国资主管单位批复，并承诺18个月内不转让所持股份。2026年2月27日，中国证券登记结算有限责任公司出具《证券过户登记确认书》，本次股份过户已于2026年2月26日完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","BK0096","BK0175","BK1521","BK0097","BK0250","BK1606","600332","BK0209","BK0239","BK1197","BK0183","600713","BK0070","BK0188","BK0196","BK0028","BK1191","BK1515","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614857431","title":"南京医药（600713）披露持股5%以上股东协议转让股份过户完成公告，2月27日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857431","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614857431?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:09","pubTimestamp":1772204954,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，南京医药报收于5.52元，较前一交易日上涨0.36%，最新总市值为72.25亿元。该股当日开盘5.5元，最高5.53元，最低5.46元，成交额达4231.17万元，换手率为0.6%。近日，南京医药发布《关于公司持股5%以上股东协议转让股份过户完成的公告》。本次转让完成后，Alliance Healthcare不再持有公司股份，广药二期基金持有公司11.04%股份。本次股份协议转让不会导致公司控股股东或实际控制人发生变化，不触及要约收购，不影响公司治理结构及持续经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700043088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609306526","title":"每周股票复盘：南京医药（600713）拟注销3.9852万股回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609306526?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:46","pubTimestamp":1770489972,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，南京医药报收于5.55元，较上周的5.53元上涨0.36%。本周，南京医药2月6日盘中最高价报5.65元。本周关注点公司公告汇总：南京医药拟注销3.9852万股回购股份并减少注册资本。2026年2月5日，南京医药召开2026年第一次临时股东会，审议通过变更回购股份用途并注销的议案，同意将2025年回购的3.9852万股股份由用于员工持股计划或股权激励变更为注销并减少注册资本。本次注销后，公司总股本将由1,308,931,240股减少至1,308,891,388股，注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609309269","title":"南京医药（600713）披露2026年第一次临时股东会决议公告，2月5日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309269?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:29","pubTimestamp":1770301756,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，南京医药报收于5.53元，较前一交易日下跌0.18%，最新总市值为72.38亿元。该股当日开盘5.54元，最高5.58元，最低5.5元，成交额达6424.45万元，换手率为0.9%。近日，南京医药集团股份有限公司发布《2026年第一次临时股东会决议公告》。关联股东南京新工投资集团有限责任公司对第三项议案回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608727730","title":"每周股票复盘：南京医药（600713）324名激励对象获解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2608727730","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608727730?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:00","pubTimestamp":1769882443,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，南京医药报收于5.53元，较上周的5.67元下跌2.47%。本周，南京医药1月26日盘中最高价报5.7元。本次共有324名激励对象符合解除限售条件，可解除限售的限制性股票数量为4,476,712股，占公司总股本的0.34%。南京医药集团股份有限公司拟将2025年回购股份中剩余的3.9852万股用途由“用于员工持股计划或股权激励”变更为“用于注销并减少注册资本”，并相应减少公司注册资本。本次注销后，公司总股本将由1,308,931,240股变更为1,308,891,388股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607500210","title":"南京医药（600713）447.67万股限售股将于1月30日解禁，占总股本0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607500210","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607500210?lang=zh_cn&edition=full","pubTime":"2026-01-30 08:12","pubTimestamp":1769731924,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，南京医药于1月30日将有447.67万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.34%。最近一年内，该股累计解禁2.56亿股，占总股本的19.56%。本次解禁后，公司还有1909.0万股限售股份，占总股本1.46%。南京医药主营业务：医药批发、医药零售、医药“互联网+”以及医药第三方物流服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000007084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606103217","title":"南京医药（600713）披露关于变更回购股份用途并注销的议案，1月28日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606103217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606103217?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:40","pubTimestamp":1769611230,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，南京医药报收于5.49元，较前一交易日下跌0.72%，最新总市值为71.86亿元。该股当日开盘5.51元，最高5.52元，最低5.43元，成交额达8127.34万元，换手率为1.15%。近日，南京医药发布《2026年第一次临时股东会材料》公告。公告显示，公司拟将2025年回购股份中剩余的3.9852万股用途由“用于员工持股计划或股权激励”变更为“用于注销并减少注册资本”，并相应减少公司注册资本。本次注销后，公司总股本将由1,308,931,240股变更为1,308,891,388股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800043102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606249683","title":"南京医药（600713）披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁事项，1月26日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606249683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606249683?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:47","pubTimestamp":1769438838,"startTime":"0","endTime":"0","summary":"近日，南京医药集团股份有限公司披露《2021年限制性股票激励计划首次授予部分第三个解除限售期股票解锁暨上市公告》。公告显示，公司于2026年1月19-20日召开第十届董事会临时会议，审议通过了《关于公司2021年限制性股票激励计划首次授予部分第三个解除限售期解除限售条件成就的议案》。本次共有324名激励对象符合解除限售条件，可解除限售的限制性股票数量为4,476,712股，占公司总股本的0.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604131925","title":"南京医药（600713）披露2026年度第一期超短期融资券发行结果，1月19日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604131925","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604131925?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:36","pubTimestamp":1768833375,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，南京医药集团股份有限公司于2026年1月15日发行了2026年度第一期超短期融资券，发行总额为5亿元，实际发行总额5亿元，发行利率1.58%，起息日为2026年1月16日，兑付日为2026年10月13日，期限270日，募集资金用于补充流动资金和偿还银行贷款。该注册额度60亿元已于2024年10月29日获交易商协会批准，有效期2年。此前公司已发行多期未到期超短期融资券。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900035896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604925311","title":"每周股票复盘：南京医药（600713）子公司使用5000万元闲置募资买理财","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925311?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:40","pubTimestamp":1768678818,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，南京医药报收于5.48元，较上周的5.52元下跌0.72%。本周，南京医药1月14日盘中最高价报5.79元，股价触及近一年最高点。南京医药当前最新总市值71.73亿元，在医药商业板块市值排名20/32，在两市A股市值排名2685/5183。本周关注点公司公告汇总：子公司福建同春使用5,000万元暂时闲置募集资金购买招商银行大额存单，年化收益率1.10%。最近十二个月内累计使用募集资金进行现金管理最高单日投入金额为7亿元，目前尚未收回本金金额为4.2亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602092535","title":"每周股票复盘：南京医药（600713）南药转债累计转股15,216股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602092535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602092535?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:26","pubTimestamp":1768073170,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，南京医药报收于5.52元，较上周的5.46元上涨1.1%。本周，南京医药1月5日盘中最高价报5.69元，股价触及近一年最高点。本周关注点公司公告汇总：南药转债累计转股数量为15,216股，占转股前总股本的0.00116%。2025年第四季度转股金额为12,000元，转股数量为2,341股。公司总股本因转股增加至1,308,931,630股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602984374","title":"南京医药（600713）披露公司及子公司使用部分暂时闲置募集资金进行现金管理到期赎回公告，1月9日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602984374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602984374?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:33","pubTimestamp":1767969191,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，南京医药报收于5.52元，较前一交易日上涨0.55%，最新总市值为72.25亿元。近日，南京医药集团股份有限公司发布公告称，公司于2026年1月9日赎回子公司福建同春使用暂时闲置募集资金购买的招商银行单位大额存单，本金6,000万元全部收回，获得理财收益16.5万元，收益符合预期，资金已归还至募集资金专用账户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774940123427,"stockEarnings":[{"period":"1week","weight":0.0826},{"period":"1month","weight":-0.0507},{"period":"3month","weight":-0.026},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.0683},{"period":"ytd","weight":-0.0403}],"compareEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0576},{"period":"3month","weight":-0.0105},{"period":"6month","weight":0.0104},{"period":"1year","weight":0.1707},{"period":"ytd","weight":-0.0115}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"51638人(较上一季度减少1.73%)","perCapita":"24977股","listingDate":"1996-07-01","address":"江苏省南京市雨花台区安德门大街55号2幢","registeredCapital":"130889万元","survey":" 南京医药集团股份有限公司的主营业务是医药批发、医药零售、医药“互联网+”业务以及医药第三方物流服务业务。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务业务。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。","listedPrice":5.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南京医药,600713,南京医药股票,南京医药股票老虎,南京医药股票老虎国际,南京医药行情,南京医药股票行情,南京医药股价,南京医药股市,南京医药股票价格,南京医药股票交易,南京医药股票购买,南京医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}